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Abstract
Objectives: To assess the clinical utility of elective neck dissection in node-negative recurrent laryngeal carcinoma
after curative radiotherapy for initial early glottic cancer.
Methods: A retrospective review was undertaken of 110 consecutive early glottic cancer patients who developed
laryngeal recurrence after radiotherapy (34 recurrent T1, 36 recurrent T2, 29 recurrent T3 and 11 recurrent T4a) and
received salvage laryngeal surgery between 1995 and 2005.
Results: Six patients presented with laryngeal and neck recurrence and underwent salvage laryngectomy with
therapeutic neck dissection, 97 patients with recurrent node-negative tumours underwent salvage laryngeal
surgery without neck dissection and only 7 underwent elective neck dissection. No occult positive lymph nodes
were documented in neck dissection specimens. During follow up, only three patients with neck failure were
recorded, all in the group without neck dissection. There was no significant association between the irradiation
field (larynx plus neck vs larynx) and the development of regional failure. A higher rate of post-operative
pharyngocutaneous fistula development occurred in the neck dissection group than in the group without neck
dissection (57.2 per cent vs 13.4 per cent, p= 0.01). Multivariate logistic regression analysis showed that early
(recurrent tumour-positive, node-positive) or delayed (recurrent tumour-positive, node-negative) neck relapse
was not significantly related to the stage of the initial tumour or the recurrent tumour. An age of less than 60
years was significantly associated with early neck failure (recurrent tumour-positive, node-positive).
Conclusion: Owing to the low occult neck disease rate and high post-operative fistula rate, elective neck
dissection is not recommended for recurrent node-negative laryngeal tumours after radiation therapy if the initial
tumour was an early glottic cancer.
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Introduction
Early glottic cancer can be treated with surgery or
radiotherapy (RT), with no significant difference in
oncological outcome. However, RT appears to ensure
better voice and swallowing results.1 Nevertheless,
the recurrence rate after primary RT is 5–13 per cent
for tumour–node–metastasis (TNM) stage T1 and
25–30 per cent for T2 carcinomas.
2,3 Surgery is the
mainstay of salvage treatment in patients with recur-
rence after RT failure,4,5 but management of recurrent
clinically diagnosed node-negative (N0) neck tumours
remains controversial and, at the time of salvage laryn-
geal surgery, surgeons must decide whether or not to
perform elective neck dissection. Previous reports indi-
cate an incidence of 10–28 per cent occult neck metas-
tasis in persistent and recurrent laryngeal disease after
primary RT.6–9 Accurate restaging with scrupulous
reassessment of the nodal status cannot completely
rule out the presence of occult neck disease.10–12
Small nodal metastases are still a diagnostic challenge
despite continuing improvements in imaging techni-
ques. Computed tomography (CT), magnetic resonance
imaging (MRI), positron emission tomography and
ultrasound-guided fine needle aspiration cytology are
all generally used in clinical practice to stage head
and neck cancers, and can be useful for detecting cer-
vical lymph node metastases. However, their diagnos-
tic accuracy for sub-centimetre metastases and
micrometastases is limited. Positron emission tomog-
raphy has a low specificity and sensitivity for nodal
metastases of diameter less than 6 mm.13,14 Recently,
CT perfusion scans have been shown to depict nodal
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metastases of less than 1 cm in diameter.15 In untreated
patients, cervical lymphatic tumour spread follows a
predictable path;10 this knowledge has led to improve-
ments in the surgical management of clinically staged
N0 laryngeal cancer.
11,12 Nowadays, it is widely
accepted that the incidence and location of occult
metastases are related to tumour stage and site.
Selective neck dissection of levels II–IV (formerly
known as ‘jugular node dissection’10) is considered
adequate in patients with clinically staged N0 laryn-
geal cancer, while modified radical neck dissection
is now considered obsolete.11,12 Furthermore, to min-
imise post-operative morbidity, super-selective dissec-
tion of sublevels IIa–III has recently been proposed
because of the rare involvement of sublevel IIb and
level IV in clinically staged N0 laryngeal carcin-
omas.16,17 In a previously irradiated neck, however,
the usual regional lymphatic pathway for both the
larynx and neck may have been extensively modified
by radiation-induced sclerosis of the lymphatic
vessels. Hence, a post-RT recurrent laryngeal tumour
could spread to lymph nodes beyond the original pre-
dicted pathway. To date, there are no consistent data
describing the prevalence of neck metastases and the
incidence and location of occult neck metastases fol-
lowing RT failure for initial early glottic cancer.
This study aimed to investigate the appropriateness
of elective neck dissection during salvage laryngeal
surgery in patients with recurrent clinically staged N0
tumours following RT failure for initial early glottic
cancer. We also aimed to identify the subpopulation
at the highest risk of occult neck disease and the neck
levels at the highest risk of regional tumour spread.
Materials and methods
We assessed all patients from 1995 to 2005 with local
recurrence of early laryngeal cancers (T1–2N0) follow-
ing elective RT, who had undergone salvage surgery.
Inclusion criteria were no previous treatment, prim-
ary curative RT for early glottic carcinoma (T1–2N0),
biopsy-proven laryngeal carcinoma after radiation,
and salvage surgery. Our case series comprised 107
male patients and 3 female patients, with a median
age of 63.2 years (range 47–83 years). Tumours had
been initially staged as T1N0 in 75 patients and as
T2N0 in 35 patients. The total dose varied from 60 to
70 Gy: 69 patients (62.7 per cent) received a mean
dose of 65.0± 3.0 Gy to the larynx alone, while 41
patients (37.3 per cent) were irradiated with a mean
dose of 64.3± 2.3 Gy to the larynx and a mean dose
of 52.8± 5.0 Gy to the neck. Follow-up time was cal-
culated from the date of salvage surgery to the date of
the last follow up or death. Follow up ranged from 1 to
200 months, with a mean of 45.42± 44.36 months.
Head and neck examinations were scheduled every
month for the first year, every two months for the
second year, every three months for the third year,
and every six months thereafter until the fifth year.
Magnetic resonance imaging and/or CT scans of the
head and neck were performed twice a year for the
first three years, and then annually. Patients with suspi-
cious lesions underwent panendoscopy with biopsy
and imaging. Persistent and recurrent laryngeal
cancers were originally classified according to the
current TNM Classification of Malignant Tumours;
for this study, each tumour was re-evaluated and
restaged according to the seventh edition of the TNM
staging system, using information in the clinical
records.18 Radiological criteria to define a N0 neck
tumour were based on the characterisation of lymph
nodes detected by a contrast-enhanced CT scan: diam-
eter less than 10 mm, no central necrosis and no con-
trast enhancement of the lymph node capsule.11 No
specific indications for elective neck dissection were
used in this study. Therefore, elective neck procedures
were performed according to the surgeon’s preference.
The extent of neck dissection ranged from selective
neck dissection of levels II–IV to comprehensive
modified radical neck dissection. Modified radical
neck dissection was performed in the earlier cases
prior to implementation of an institute policy recom-
mending selective neck dissection (levels II–IV).10
Descriptive statistics were compared using Student’s
t-test for continuous variables and Fisher’s exact test for
categorical variables. The Kaplan–Meier method was
used for survival analysis. All analyses were
performed using STATA version 10.0 software
(StataCorp, College Station, Texas, USA). A p value
of less than 0.05 was considered statistically significant.
Results
After RT, the median time to local recurrence was
23.5± 33.2 months (range 1–216 months, 95 per
cent confidence interval (CI) 17.25 to 29.8). The
most common salvage procedure was total laryngect-
omy (90 patients, 81.8 per cent), while only 20 patients
(18.2 per cent) underwent salvage partial laryngectomy
without elective or therapeutic neck dissection.
Restaging showed 34 recurrent T1, 36 recurrent T2,
29 recurrent T3 and 11 recurrent T4a tumours; 6 patients
also had clinically staged neck metastases (1 recurrent
T4aN1, 2 recurrent T2N1, 1 recurrent T3N1, 1 recurrent
T2N2b and 1 T2N2c). Neck level II was involved in four
cases (three with N1 and one with N2btumours), and
neck levels III and IV were involved in only two
cases; all of these patients underwent radical neck dis-
section or modified radical neck dissection. Of the
remaining 104 patients, 97 were managed using a
‘wait-and-see’ protocol for neck relapse and 7 patients
with recurrent N0 tumours underwent elective neck dis-
section: 2 with ipsilateral selective neck dissection
(levels II–IV), 2 with bilateral selective neck dissection
(levels II–IV) and 3 with ipsilateral modified radical
neck dissection. The characteristics of both groups at
original diagnosis are shown in Table I; tumour
stages were similar in both patient groups. No occult
lymph node metastases were documented in the
seven cases of elective neck dissection.
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Post-operative medical and surgical complications
are summarised in Table II. There was a higher rate
of post-operative complications in the elective neck dis-
section group than in the ‘wait-and-see’ group (71.4 per
cent vs 26.8 per cent, respectively, p= 0.02, Fisher
exact test), resulting from a higher rate of pharyngocu-
taneous fistula development (57.2 per cent vs 13.4 per
cent, respectively). Furthermore, 2 (2.1 per cent)
patients in the ‘wait-and-see’ group died as a result of
peri-operative myocardial stroke. The median follow
up after salvage surgery was 45.4± 44.4 months
(range 1–200 months, 95 per cent CI 37.04 to 53.8),
while the median time to a second local or locoregional
relapse was 36.5± 36.3 months (range 1–200 months,
95 per cent CI 29.6 to 43.4). The incidence of local,
regional and distant failure is shown in Table III. In
the ‘wait-and-see’ group, three patients (one with a
recurrent T3 tumour and two with recurrent T2
tumours) developed pathologically staged N1 or N2b
neck metastasis without local recurrence; in all cases,
level II was the only level involved. Of note, post-
operative local recurrences were significantly higher
in the neck dissection group (n= 5, 71.5 per cent)
than in the ‘wait-and-see’ group (n= 27, 27.8 per
cent, p= 0.028). Distant metastases were detected in
two patients in the ‘wait-and-see’ group (2.1 per
cent). At the end of the study, the overall survival
rate was 42.9 per cent in neck dissection patients, and
62.0 per cent in the ‘wait-and-see’ group (shown in
Figure 1). No significant differences in overall survival
were observed between patients with recurrent node-
positive (N+) tumours receiving therapeutic neck dis-
section at the time of salvage laryngectomy and those
with recurrent N0 tumours receiving elective neck dis-
section or salvage laryngectomy alone (p= 0.071;
Figure 2).
Multivariate regression analysis demonstrated that an
initial T1 stage tumour and age less than 60 years cor-
relate with a higher risk of neck failure after curative RT
(Table IV; p= 0.04 and p= 0.038, respectively).
Indeed, Fisher’s exact test confirmed that a younger
age was significantly associated with a risk of neck
metastasis following local recurrence (p< 0.001).
TABLE I
PATIENT CHARACTERISTICS
Characteristic Elective neck dissection group (n= 7) ‘Wait-and-see’ group (n= 97) p value
Median age (years) 60.9± 6.3 67± 9.6 0.10
Sex
– Male 6 (85.7%) 95 (98%) 0.19
– Female 1 (14.3%) 2 (2%)
Field of radiation therapy
– Larynx 5 63 1.00
– Larynx & neck 2 34
Initial staging
– T1 7 (100%) 63 (65%) 0.09
– T2 0 34 (35%)
Recurrence
– T1 1 (14.3%) 33 (34%) 0.70
– T2 3 (42.9%) 29 (30%)
– T3 3 (42.9%) 25 (26%)
– T4 0 10 (10%)
Follow-up (months: range, mean± SD) 1–103, 29.3± 43.0 1–199, 48.7± 44.9 0.27
TABLE II










None 2 (28.6) 71 (73.2) 0.02
Surgical
– Salivary fistula 4 (57.2) 13 (13.4) 0.01
– Wound infection 0 (0.0) 1 (1.0) 1.0
– Wound dehiscence 0 (0.0) 1 (1.0) 1.0
– Bleeding 0 (0.0) 1 (1.0) 1.0
– Flap failure 0 (0.0) 1 (1.0) 1.0
– Revision procedure 0 (0.0) 1 (1.0) 1.0
– Pneumonia 1 (14.3) 3 (3.1) 0.24
Medical
– Cardiovascular 0 (0.0) 2 (2.1) 1.0
– Death 0 (0.0) 3 (3.1) 1.0
∗n= 7. †n= 97.
TABLE III
SITES OF RECURRENCE AFTER SALVAGE SURGERY IN
PATIENTS WHO DIED FROM THE DISEASE







None† 2 (28.5) 66 (68.0) 0.047
Local† 5 (71.5) 27 (27.8) 0.028
– Peristomal‡ 2 (40.0) 19 (70.4) 0.08
– Hypopharynx‡ 2 (40.0) 5 (18.5) 0.61
– Larynx (for partial
salvage
laryngectomy)‡
1 (20.0) 3 (11.1)
Regional (neck)† 0 (0.0) 3 (3.1) 1.0
Distant† 0 (0.0) 2 (2.1) 0.0
∗One patient had multiple metastatic sites (neck+ hypopharynx);
†percentage of total group; ‡percentage of patients with local
tumours.
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Discussion
Radiotherapy (RT) is often indicated for early glottic
cancers to preserve organ function and post-treatment
voice quality compared with surgery. Unfortunately,
RT may be unsuccessful and some patients will experi-
ence recurrence or persistent laryngeal cancer. The
Union for International Cancer Control and American
Joint Committee on Cancer staging criteria for laryn-
geal recurrences are identical to those for untreated
primary tumours, except for addition of the prefix
‘recurrent’ applied to the TNM categories. Regional
recurrence after curative RT correlates with poor prog-
nosis, independent of the initial tumour stage.19,20 Our
data confirmed this finding: we showed that prognosis
after salvage laryngectomy was more strongly asso-
ciated with TNM restaging than with initial staging.
Previous studies reported a rate of occult neck metas-
tases of 4–28 per cent in supraglottic and glottic cancer
patients treated with RT alone.6,7,21 This is especially
true for advanced laryngeal carcinomas after failure
of chemoradiation protocols; however, there are few
data for early glottic cancers that recur after RT. In
fact, at the time of first diagnosis, these patients have
a very low risk of occult neck disease. After RT
failure, both the risk of cancer spreading to other laryn-
geal sites and frequent progression or upstaging of per-
sistent or recurrent lesions may lead to a higher rate of
occult neck disease. We analysed only cases of persist-
ent or recurrent cancers after primary RT that initially
presented as early glottic laryngeal carcinomas. To
the best of our knowledge, no other studies have con-
sidered this specific patient cohort. Thus, there is
very little information on the correct management of
recurrent N0 neck tumours when salvage laryngectomy
is indicated.
In our case series, 6 patients who underwent thera-
peutic neck dissection after primary RT had recurrent
N+ tumours (5.5 per cent; 4 with N1 and 2 with N2
tumours) and 3 out of 97 patients in the ‘wait-and-
see’ group had neck recurrence at follow up after
salvage laryngeal surgery. Pathological examination
showed that no neck dissection patient had occult
neck disease and none experienced neck treatment
failure during follow up. Thus, in our series, neck
disease was detected in only nine patients (8.7 per
cent; six with recurrent N+ tumours at the end of
primary RT and three with recurrent N+ tumours
within the ‘wait-and-see’ group at follow up). There
was a higher rate of neck metastasis development in
patients aged less than 60 years (p< 0.001), and an
increased risk in those who originally presented with
a T2 glottic carcinoma or at a younger age (p= 0.04
and p= 0.038, respectively). Furthermore, the overall
neck recurrence rate was 2.9 per cent after salvage
laryngeal surgery. This low incidence of neck disease
may be related to radiation-induced neck sclerosis
sealing lymphatic vessels and thus hampering cancer
lymphatic embolisation. Nevertheless, extension of
the irradiation field to include the neck (larynx plus
FIG. 2
Kaplan–Meier curve showing overall survival after curative radi-
ation therapy for node-negative (N0) vs node-positive (N+)
tumours. (p= 0.071)
TABLE IV
MULTIVARIATE ANALYSIS OF NECK FAILURE RISK AFTER CURATIVE RADIATION THERAPY
Parameter Correlation coefficient SEM z-score p value 95% CI
Sex −0.048 0.14 −0.33 0.74 −0.34, 0.24
Age −0.14 0.067 −2.11 0.038 −0.27, 0.08
Radiation field (larynx vs larynx+ neck) 0.055 0.068 0.81 0.419 −0.08, 0.19
T1 −0.14 0.69 −2.09 0.04 −0.28, 0.06
SEM= standard error of the mean; CI= confidence interval; T1= tumour–node–metastasis stage T1
FIG. 1
Kaplan–Meier curve showing overall survival of patients who
underwent simultaneous elective neck dissection and salvage laryn-
geal surgery (NP) and those who underwent only salvage laryngeal
surgery (WP) for recurrent early glottic cancer. (p= 0.7)
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neck levels II–IV) did not completely protect from
regional failure development, although it seemed to
delay it. In fact, all six patients with recurrent N+
tumours received RT to the larynx alone, while the
radiation field was extended to the neck in all three
recurrent N0 patients.
• Surgery is the main salvage treatment for
laryngeal cancer patients with recurrence
after radiotherapy
• The management of clinically negative
cervical lymph nodes in persistent or
recurrent laryngeal cancers after primary
radiotherapy is controversial
• For initial early glottic cancer recurring after
radiotherapy without clinical or radiological
lymph node involvement, salvage laryngeal
surgery alone may be appropriate regardless
of restaging
• Elective neck dissection is not recommended
because of the increased risk of post-operative
complication with no survival advantage
The five-year survival rate was 57.14 per cent in the
small group of neck dissection patients and 64.6 per
cent in the ‘wait-and-see’ group; however, the differ-
ence was not statistically significant (p= 0.7).
Nevertheless, this result is consistent with the demon-
strated impact of lymph node metastases on head and
neck cancer prognosis. Several recent studies con-
cluded that neck dissection is indicated for recurrent
advanced stage laryngeal cancer.7,22 However, these
studies failed to demonstrate a survival advantage in
patients who underwent neck dissection. Some
authors have advocated bilateral neck dissection for
all advanced stage (T3 and T4) glottic recurrences and
for all supraglottic recurrences regardless of stage.22
In our series, there were 38 recurrent T3–4 cancers,
and 8 of these had supraglottic involvement in the
recurrence. Furthermore, we documented involvement
of the supraglottic larynx in 12 T2 recurrences.
Among these 50 patients, 4 underwent elective neck
dissection with no evidence of lymph node metastasis
at pathological examination; in the remaining 46
patients, only 1 showed neck relapse at follow up.
Furthermore, neck dissection did not lead to an
overall survival benefit in our case series, and neck dis-
section did not provide additional protection from local
recurrence (71.5 per cent vs 27.8 per cent, p= 0.028).
Nevertheless, no regional failure was recorded in
neck dissection patients, while only three patients in
the ‘wait-and-see’ group experienced neck failure
(0.0 per cent vs 3.1 per cent, p= 1.0). However,
these data are not consistent with other reports.21,22
Conversely, neck dissection during salvage laryngeal
cancer was associated with an increased rate of post-
operative complications (71.4 per cent in the neck dis-
section group vs 26.8 per cent in the ‘wait-and-see’
group, p= 0.02), especially pharyngocutaneous fis-
tulas (Table II; 57.2 per cent), as previously
reported.22–24 These discrepancies suggest a selection
bias toward treating RT-recurrent laryngeal carcinoma
patients with salvage laryngeal surgery and concomi-
tant neck dissection, and a possible negative impact
of uni- or bilateral neck procedures on devascularised
irradiated soft neck tissue, associated with a higher
risk of locoregional complications, especially pharyn-
gocutaneous fistulas.
Conclusion
Patients who experience recurrent or persistent laryn-
geal cancer after primary RT for early glottic cancer
without clinical and radiological involvement of cer-
vical lymph nodes benefit from exclusive salvage
laryngeal surgery. The prevalence of neck disease in
these patients is less than 10 per cent, and the incidence
of occult neck disease is less than 5 per cent. This is
also true for recurrent T3–4 lesions and for extension
to the supraglottic or hypoglottic areas. Moreover,
elective neck dissection is not recommended in these
cases because it exposes patients to an increased risk
of post-operative complications without a definite
survival advantage.
References
1 Higgins KM, Shah MD, Ogaick MJ, Enepekides D. Treatment
of early-stage glottic cancer: meta-analysis comparison of
laser excision versus radiotherapy. J Otolaryngol Head Neck
Surg 2009;38:603–12
2 Motamed M, Laccourreye O, Bradley PJ. Salvage conservation
laryngeal surgery after irradiation failure for early laryngeal
cancer. Laryngoscope 2006;116:451–5
3 Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S et al.
Radical radiotherapy for early glottic cancer: Results in a series
of 1087 patients from two Italian radiation oncology
centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol
Phys 2005;63:1378–86
4 Agra IM, Ferlito A, Takes RP, Silver CE, Olsen KD, Stoeckli SJ
et al. Diagnosis and treatment of recurrent laryngeal cancer fol-
lowing initial nonsurgical therapy. Head Neck 2012;34:727–35
5 Sher DJ, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ,
Goguen LA et al. Efficacy and toxicity of reirradiation using
intensity-modulated radiotherapy for recurrent or second
primary head and neck cancer. Cancer 2010;116:4761–8
6 Yuen AP, Wei WI, Wong SH. Critical appraisal of watchful
waiting policy in the management of N0 neck of advanced
laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996;
122:742–5
7 Yao M, Roebuck JC, Holsinger FC, Myers JN. Elective neck
dissection during salvage laryngectomy. Am J Otolaryngol
2005;26:388–92
8 Deganello A, Gallo O, De Cesare JM, Ninu MB, Gitti G, de’
Campora L et al. Supracricoid laryngectomy as salvage
surgery for radiation therapy failure. Head Neck 2008;30:
1064–71
9 Zbären P, Christe A, Caversaccio MD, Stauffer E, Thoeny HC.
Pretherapeutic staging of recurrent laryngeal carcinoma: clinical
findings and imaging studies compared with histopathology.
Otolaryngol Head Neck Surg 2007;137:487–91
10 Spiro RH, Gallo O, Shah JP. Selective jugular node dissection in
patients with squamous carcinoma of the larynx or pharynx. Am
J Surg 1993;166:399–402
11 Deganello A, Gitti G, Meccariello G, Parrinello G, Mannelli G,
Gallo O. Effectiveness and pitfalls of elective neck dissection in
ELECTIVE NECK DISSECTION FOR LARYNGEAL CANCER RECURRENCE 1093
N0 laryngeal cancer. Acta Otorhinolaryngol Ital 2011;31:
216–21
12 Gallo O, Deganello A, Scala J, De Campora E. Evolution of
elective neck dissection in N0 laryngeal cancer. Acta
Otorhinolaryngol Ital 2006;26:335–44
13 Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS,
Leemans CR. Positron emission tomography using [18F] fluor-
odeoxyglucose (FDG-PET) in the clinically negative neck: is it
likely to be superior? Eur Arch Otorhinolaryngol 2004;261:
479–83
14 Phillips MH, Smith WS, Parvathaneni U, Laramore GE. Role of
positron emission tomography in the treatment of occult disease
in head-and-neck cancer: a modeling approach. Int J Radiat
Oncol Biol Phys 2011;79:1089–95
15 Trojanowska A, Trojanowski P, Bisdas S, Stas´kiewicz G, Drop
A, Klatka J et al. Squamous cell cancer of hypopharynx and
larynx – evaluation of metastatic nodal disease based on com-
puted tomography perfusion studies. Eur J Radiol 2012;81:
1034–9
16 Ferlito A, Silver CE, Rinaldo A. Selective neck dissection (IIA,
III): a rational replacement for complete functional neck dissec-
tion in patients with N0 supraglottic and glottic squamous car-
cinoma. Laryngoscope 2008;118:676–9
17 Santoro R, Franchi A, Gallo O, Burali G, de’ Campora E. Nodal
metastases at level IIb during neck dissection for head and neck
cancer: clinical and pathologic evaluation. Head Neck 2008;30:
1483–87
18 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti
A, eds. American Joint Committee on Cancer Staging Manual,
7th edn. New York: Springer, 2009
19 Lacy PD, Piccirillo JF. Development of a new staging system for
patients with recurrent laryngeal squamous cell carcinoma.
Cancer 1998;83:910–7
20 Leon X, Lopez M, Garcia J, Viza I, Gich I, Quer M. Recurrent
laryngeal squamous cell carcinoma: rTNM versus composite
laryngeal recurrence staging system. Proposal for a modification
of the CLRSS to improve patient classification. Head Neck
2008;30:939–45
21 Bohannon IA, Desmond RA, Clemons L, Magnuson JS, Carrol
WR, Rosenthal EL. Management of the N0 neck in recurrent
laryngeal squamous cell carcinoma. Laryngoscope 2010;120:
58–61
22 Wax MK, Touma BJ. Management of the N0 neck during
salvage laryngectomy. Laryngoscope 1999;109:4–7
23 Ganly I, Patel S, Matsuo J, Singh B, Kraus D, Boyle J et al.
Postoperative complications of salvage total laryngectomy.
Cancer 2005;103:2073–81
24 Gallo O, Deganello A, Gitti G, Santoro R, Senesi M, Scala J
et al. Prognostic role of pneumonia in supracricoid and supra-
glottic laryngectomies. Oral Oncol 2009;45:30–8
Address for correspondence:
Prof O Gallo,
Academic Clinic of Otolaryngology-Head and Neck Surgery,
University of Florence,
Viale Morgagni,
85 50134 Firenze, Italy
Fax: +39 0557947939
E-mail: oreste.gallo@unifi.it
Prof O Gallo takes responsibility for the integrity of the content of
the paper
Competing interests: None declared
A DEGANELLO, G MECCARIELLO, B BINI et al.1094
